ArticleThe American journal of case reports2025
Unusual Presentation of Multiple Myeloma as a Liver Tumor at Initial Diagnosis: A Case Report.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Multiple myeloma (MM) is a hematologic cancer marked by malignant plasma cells in the bone marrow, often leading to bone pain, anemia, and renal issues. Rarely, MM presents as extramedullary myeloma in organs such as the liver, and is associated with a poor prognosis. CASE REPORT We report a 64-year-old woman with a history of aortic stenosis and transient ischemic attack who presented with severe anemia, epistaxis, and fatigue. Initial test results showed elevated liver enzymes, hypercalcemia, and kidney injury, with imaging revealing suspected liver metastases. Cancer markers, such as carcinoembryonic antigen, cancer antigen 15-3, and cancer antigen 125 were elevated. Liver biopsy showed plasma cells positive for CD138, CD38, and CD56, confirming MM. Additional tests found IgA kappa monoclonal proteins and 60% plasma cells in bone marrow, without bone lesions. The patient required an extended hospital stay, due to recurrent pleural effusions, hypercalcemia, and cholangitis requiring stent placement. After recovery from complications, including COVID-19, she was treated with 7 cycles of daratumumab-dexamethasone-lenalidomide and was scheduled for an autologous stem cell transplant. After 4 months of treatment, the patient had positive clinical outcomes in myeloma parameters and liver lesions. The patient had improved hemoglobin, white blood cells, neutrophils, and platelets. The patient's IgA decreased, hepatic enzymes improved, monoclonal protein bands disappeared, and liver lesions resolved. CONCLUSIONS This case highlights an uncommon MM presentation with liver involvement, underscoring the importance of considering MM in the differential diagnosis of atypical liver lesions and of early identification to improve treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.